Latest KFF Health News Stories
What the Health? From KFF Health News: Time’s Up for Expanded ACA Tax Credits
A last-minute push from Democrats and four moderate Republicans will force a House vote on renewing enhanced premium tax credits for Affordable Care Act plans, but not until January. That means millions will have to choose between paying dramatically more or dropping coverage next year. Meanwhile, the Centers for Disease Control and Prevention officially drops the federal recommendation for newborns to receive a hepatitis B shot. Tami Luhby of CNN, Alice Miranda Ollstein of Politico, and Lizzy Lawrence of Stat join KFF Health News’ Julie Rovner to discuss those stories and more. Also this week, Rovner interviews Tony Leys, who wrote the latest “Bill of the Month” feature, and the panel discusses the year’s biggest developments in health policy.
Qué significa la decisión sobre la vacuna contra la hepatitis B para la gente
Un comité de los Centros para el Control y Prevención de Enfermedades votó para poner fin a la recomendación universal de aplicar la vacuna contra la hepatitis B a los recién nacidos.
Vaccine Panel’s Hepatitis B Vote Signals Further Turbulence for Immunization Policy, Public Trust
Clinicians and epidemiologists warn the decision to no longer recommend the birth dose of the hepatitis B vaccine could unravel decades of progress and expose newborns to a deadly, preventable disease.
What the Health? From KFF Health News: Crunch Time for ACA Tax Credits
Dec. 15 is the deadline to sign up for Affordable Care Act plans that begin Jan. 1, and Congress remains at odds over letting expanded tax credits for the plans’ premiums expire and increasing the cost of insurance for millions of Americans. Meanwhile, HHS Secretary Robert F. Kennedy Jr. continues to remake vaccine policy to reflect ideology rather than science. Anna Edney of Bloomberg News, Maya Goldman of Axios, and Sheryl Gay Stolberg of The New York Times join KFF Health News’ Julie Rovner to discuss those stories and more. Also this week, Rovner interviews Georgetown professor Linda Blumberg about the GOP’s health plans.
In RFK Jr.’s Upside-Down World of Vaccines, Panel Votes To End Hepatitis B Shot at Birth
A session of a vaccine panel dominated by skeptics was chaotically at odds with past practices of the CDC, which HHS Secretary Robert F. Kennedy Jr. has described as a “cesspool of corruption.” His crew voted to end a 34-year recommendation to vaccinate newborns against hepatitis B.
Autoridades quieren retrasar la vacuna contra la hepatitis B. Lo que los padres deben saber
Desde 1991, una dosis de la vacuna al nacer es hasta 90% efectiva para prevenir la infección transmitida por la madre si se administra en las primeras 24 horas de vida.
RFK Jr. Wants To Delay the Hepatitis B Vaccine. Here’s What Parents Need To Know.
A CDC panel is reconsidering the birth dose of the hepatitis B vaccine. Renewed doubt could lead to fewer kids getting vaccinated, leaving them vulnerable to an incurable, preventable virus that can be acquired by indirect contact with infected blood.
In Hepatitis B Vaccine Debate, CDC Panel Sidesteps Key Exposure Risk
At a recent meeting of a key vaccine advisory panel, members debated changes to the timing of hepatitis B vaccination, while largely ignoring the risk of early childhood transmission from day care or household contact. A few days later, President Donald Trump did the same.
Watch: Fired CDC Chief Says RFK Jr. Demanded She Roll Back Vaccine Policies Without Evidence
Susan Monarez and former Centers for Disease Control and Prevention chief medical officer Debra Houry described turmoil in an agency dominated by anti-vaccine political officials nominated by Health and Human Services Secretary Robert F. Kennedy Jr.
RFK Jr.’s Vaccine Panel Expected To Recommend Delaying Hepatitis B Shot for Children
A federal vaccine panel, recently reshaped by Health and Human Services Secretary Robert F. Kennedy Jr., is expected to vote on delaying the hepatitis B shot for newborns. Pediatricians warn that could open the door to a comeback for a disease virtually eradicated among U.S. children.
Resurge la hepatitis C, ¿podrá el plan de Biden eliminar este viejo flagelo en cinco años?
Se calcula que el 40% de los más de 2 millones de personas con hepatitis C en Estados Unidos ni siquiera saben que la tienen, pero el virus puede estar dañando silenciosamente su hígado, causando cicatrices, insuficiencia hepática o cáncer de hígado.
Hep C’s Number Comes Up: Can Biden’s 5-Year Plan Eliminate the Longtime Scourge?
Before covid-19, hepatitis C held the distinction of claiming more American lives each year than any other infectious disease — that’s despite the marketing of several relatively affordable, highly effective treatments.
Pharma Sells States On ‘Netflix Model’ To Wipe Out Hep C. But At What Price?
Manufacturers of lucrative drugs say they’re offering discounts off the high sticker prices ― but taxpayers footing the big bills might never know what the state is paying or if it’s getting a good deal.
Dramático aumento de la hepatitis A en todo el país
A la sombra de la epidemia de opioides, el virus de la hepatitis A se está abriendo camino en la población general. Más de la mitad de los estados han tenido, o tienen brotes. Y los fondos para frenarlos son insuficientes.
Hepatitis A Races Across The Country
In the wake of the opioid crisis, the highly communicable hepatitis A virus is spreading in more than half the states and making its way into the general public. Underfunded health officials are valiantly trying to fight it with vaccines.
Florida es el último estado republicano en adoptar programa de intercambio de jeringas
Un programa piloto en el condado de Miami-Dade demostró la efectividad de esta intervención de salud pública. Una nueva ley podría ampliarla a otros condados.
Florida Is The Latest Republican-Led State To Adopt Clean Needle Exchanges
Florida has struggled for years with opioid overdoses — and the highest rate of HIV infection in the U.S. Lawmakers now hope needle exchanges and a “harm reduction” approach could help save lives.
Medicaid en Puerto Rico no cubre medicamentos que curan la hepatitis C
A pesar que podría haber más de 11,000 casos en la isla, el Medicaid, que tiene un sistema de financiamiento distinto al de los estados, no cubre estos medicamentos.
Medicaid Patients In Puerto Rico Don’t Get Coverage For Drugs To Cure Hepatitis C
The program that provides health care for about half of the U.S. territory’s population cannot afford to cover the drugs.
Hep C And Drug Abuse Often Go Hand In Hand, But Screening For Infection Lags
As the number of people who inject drugs has soared, the rate of hepatitis C infection has climbed steeply, too, because the disease can be tied to sharing needles. Yet many drug patients are not checked for the virus that can damage the liver.
